Researchers Use Nanoparticles to Test Treatment for Liver Disease

June 25, 2018 | Katie Neith

In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.

Continue Reading

World Cancer Day: New treatments and cures start with collaborations

February 3, 2017 | Denise Heady

Defeating cancer cannot be done alone. It requires a team approach. Here are just a few examples of how City of Hope scientists and physicians are working together to create leading-edge approaches to end cancer.

Breakthroughs on the Road Toward a CMV Vaccine

January 20, 2017 | Letisia Marquez

A team from City of Hope is working on a vaccine for congenital cytomegalovirus (CMV), symptoms of which can range from hearing and vision loss to intellectual disability to small head size to frequent seizures. More than half of adults over the age of 40 are infected with the virus.

Study finds Triplex vaccine safe for use in healthy populations

December 14, 2016 | City of Hope

Data published in Blood supports ongoing phase 2 trial of Triplex in allogeneic hematopoietic stem cell transplant recipients.

Experimental Treatment Using Breast Cancer Vaccine Gives Patient New Hope

December 8, 2016 | Samantha Bonar

City of Hope patient Susan Young - diagnosed with late-stage triple negative breast cancer - has had a remarkable response to a revolutionary new treatment, a combination of the p53 cancer vaccine and a drug that blocks a specific cancer-aiding protein.

City of Hope researchers test vaccine targeting a harmful virus in stem cell transplant patients

November 3, 2016 | By City of Hope

Patients undergoing a stem cell or solid organ transplant from a donor are at a particularly high risk of experiencing complications associated with CMV, which is why City of Hope researchers are working so diligently to develop a vaccine that combats the virus.

CMV vaccine reduces complications after stem cell transplants

December 23, 2015 | Jyoti Madhusoodanan

Between 50 and 80 percent of adults in the United States harbor a virus named CMV, or cytomegalovirus. CMV lies latent and harmless in most people. But in pregnant women or immunocompromised patients, the virus can flare up to cause infections and a form of hepatitis.

CMVPepVax vaccine reduces complications post stem cell transplants

December 23, 2015 | Jyoti Madhusoodanan

City of Hope researchers report that the vaccine CMVPepVax is safe and elicits a protective immune response when administered to stem cell transplant recipients.